Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$166.91 USD
-2.73 (-1.61%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $166.81 -0.10 (-0.06%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Charles River Laboratories International, Inc. has a market cap of $8.33B, which represents its share price of $169.64 multiplied by its outstanding shares number of 49.12M. As a mid-cap company, CRL's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CRL 166.91 -2.73(-1.61%)
Will CRL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRL
Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Charles River Q2 Earnings Preview: What's in Store for the Stock?
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Is it Prudent to Retain Charles River Stock in Your Portfolio Now?
Other News for CRL
CRL Crosses Below Key Moving Average Level
Charles River (CRL) Explores New Partnership for Funding Opportunities
Charles River, BioTech Social to pursue crowdfunding partnership
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership | CRL Stock News
ClearBridge Growth Fund Q2 2025 Commentary